Plenty of interest in BOE at the moment. That will likely flow on to MEU. Visible gold in drill samples on recent report would suggest a good announcement on the way for AT as well. DYOR.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
